238 new codes and 21 deleted, effective October 1, 2026. The complete FY2027 ICD-10-CM list by chapter, plus the cardiomyopathy, arrhythmia, and Z-code changes that affect HCC capture.
The FY2027 ICD-10-CM update adds 238 new codes and removes 21, effective October 1, 2026, per the official CMS FY2027 order file. The additions cluster in injury and poisoning (85), pregnancy and childbirth (56), and musculoskeletal (33). For risk adjustment coders the headline is not the count. It is where they landed: dilated cardiomyopathy, a set of inherited and arrhythmia conditions, and a new block of Z codes that change how history and exposure get captured.
This is the complete, code-by-code list, grouped by ICD-10-CM chapter, plus the deleted codes and the ones that were restructured rather than truly removed. Every code and description comes straight from the official CMS FY2027 files. Bookmark it: when CMS posts the FY2027 risk adjustment mappings, we will add the HCC impact below. For prior-year context, see our FY2026 ICD-10-CM guidelines recap and the April 2026 ICD-10-CM update.
*Source: the official CMS FY2027 ICD-10-CM files (2027 Code Descriptions in Tabular Order), via the CMS ICD-10 page. Effective for encounters October 1, 2026 through September 30, 2027. Counts reflect a direct diff of the FY2027 and FY2026 order files. Verify against the CMS files before relying on any code for billing.*
FY2027 ICD-10-CM changes at a glance, effective October 1, 2026
As of October 1, 2026, ICD-10-CM expands by a net 217 codes. The 238 additions cluster in Chapter 19 (85 codes, mostly toxic-effect expansions for organic solvents, alkenes, and cycloparaffins), Chapter 15 (56 codes, ectopic pregnancy site specificity and vanishing twin detail), Chapter 13 (33 codes, osteomyelitis by site and plantar fasciitis laterality), and Chapter 21 (17 new Z codes for exposure history and gender transition). Twenty-one codes are deleted outright. Beyond those, several previously billable codes were demoted to non-billable category headers, which is the change most likely to slip past a carried-forward code list.
The FY2027 changes that matter most for risk adjustment
What happens to I42.0 dilated cardiomyopathy on October 1, 2026?
Dilated cardiomyopathy is no longer one code. I42.0 stops being billable at the cutover and becomes a category header. You code instead to I42.00 (unspecified), I42.01 (familial-genetic), or I42.09 (other). I42.8 also becomes a header, splitting into I42.81 (arrhythmogenic cardiomyopathy) and I42.89. If your templates or problem lists carry I42.0 or I42.8, they stop validating on October 1. Cardiomyopathy carries risk weight under current models, so confirm the FY2027 HCC assignment for each child code when CMS posts the mapping. For the co-morbidity context, see our heart failure HCC coding guide.
New arrhythmia and inherited cardiac codes
I49.81 (Brugada syndrome), I49.82 (ventricular bigeminy), and I47.22 (catecholaminergic polymorphic ventricular tachycardia) carve out conditions that previously fell to less specific parents. I49.8 itself becomes a non-billable header on October 1. For how arrhythmia specificity affects capture, see our atrial fibrillation HCC coding guide.
Inherited cancer predisposition gets its own block
The new QA1 category adds Lynch syndrome (QA1.71), familial cancer syndrome with BRCA1 (QA1.790) or BRCA2 (QA1.791) mutation, and Li-Fraumeni syndrome (QA1.792). Loeys-Dietz syndrome (Q87.A) and VEXAS syndrome (M04.3) also get first-time discrete codes. These conditions drive screening and surveillance, so the documentation to support them tends to be in the chart.
Gender-related history codes
Z87.8901 through Z87.8909 capture social, medical, surgical, intersex-surgery, and unspecified gender transition history, with Z87.893 for detransition and F64.A for gender identity disorder in remission.
Exposure and history Z codes
Blast overpressure (Z77.40 through Z77.49), Agent Orange (Z77.33), burn pits in a war theater (Z77.32), and gadolinium exposure (Z77.013) paired with R78.72 (abnormal gadolinium level in blood). Z86.17 adds personal history of Clostridioides difficile infection. Z68.18 (BMI 18.4 or less) and Z68.19 (BMI 18.5 to 19.9) add low-end BMI specificity that matters for malnutrition and frailty documentation.
A note on HCC mappings, and why this page will change
Last reviewed June 2026. This section updates as soon as CMS publishes the FY2027 ICD-10 to CMS-HCC crosswalk.
CMS releases the new fiscal year code descriptions first and the risk adjustment crosswalk (ICD-10 to CMS-HCC under V28) later, usually closer to the payment year. As of this writing the FY2027 mappings are not published. We are not going to guess which new codes map to an HCC, because a wrong RAF assumption is worse than no assumption at all. The moment CMS posts the FY2027 mapping, we will add the HCC and RAF impact below and update the date on this page. If you want that mapping the day it drops, the ICD-10 to HCC tool tracks the same cycle. For the model context, see what changed in CMS-HCC V28.
Deleted and restructured FY2027 codes
Most of the 21 deleted codes were restructured, not retired. The sternoclavicular sprain family (S23.420 and its 7th-character siblings) and the organic-solvent toxic-effect family (T52.8X) were broken into more specific codes, which appear in the new-code lists below. Read the full deleted list as a find-and-replace task, not a cleanup. Separately, the billable-to-header demotions noted earlier (I42.0, I42.8, I49.8) are not on this list because the parent still exists, but they stop being codeable. A carried-forward code or a saved favorite is the usual way any of these slip through after October 1.
S23.420 Sprain of sternoclavicular (joint) (ligament)S23.420A Sprain of sternoclavicular (joint) (ligament), initial encounterS23.420D Sprain of sternoclavicular (joint) (ligament), subsequent encounterS23.420S Sprain of sternoclavicular (joint) (ligament), sequelaT52.8X Toxic effects of other organic solventsT52.8X1 Toxic effect of other organic solvents, accidental (unintentional)T52.8X1A Toxic effect of other organic solvents, accidental (unintentional), initial encounterT52.8X1D Toxic effect of other organic solvents, accidental (unintentional), subsequent encounterT52.8X1S Toxic effect of other organic solvents, accidental (unintentional), sequelaT52.8X2 Toxic effect of other organic solvents, intentional self-harmT52.8X2A Toxic effect of other organic solvents, intentional self-harm, initial encounterT52.8X2D Toxic effect of other organic solvents, intentional self-harm, subsequent encounterT52.8X2S Toxic effect of other organic solvents, intentional self-harm, sequelaT52.8X3 Toxic effect of other organic solvents, assaultT52.8X3A Toxic effect of other organic solvents, assault, initial encounterT52.8X3D Toxic effect of other organic solvents, assault, subsequent encounterT52.8X3S Toxic effect of other organic solvents, assault, sequelaT52.8X4 Toxic effect of other organic solvents, undeterminedT52.8X4A Toxic effect of other organic solvents, undetermined, initial encounterT52.8X4D Toxic effect of other organic solvents, undetermined, subsequent encounterT52.8X4S Toxic effect of other organic solvents, undetermined, sequelaComplete list of new FY2027 ICD-10-CM codes
All 238 new codes, grouped by ICD-10-CM chapter. Codes tagged "category header" are non-billable and need an additional character. Always code to the highest level of specificity the record supports. (Source: the CMS FY2027 ICD-10-CM order file, effective October 1, 2026.)
Chapter 2. Neoplasms (3 new)
C78.31 Secondary malignant neoplasm of larynx (billable)C78.32 Secondary malignant neoplasm of pharynx (billable)C79.83 Secondary malignant neoplasm of oral cavity (billable)Chapter 3. Blood & Immune Disorders (2 new)
D69.11 Glanzmann thrombasthenia (billable)D69.19 Other qualitative platelet defects (billable)Chapter 4. Endocrine, Nutritional & Metabolic (3 new)
E89.83 Postprocedural hypoglycemia following a procedure (category header)E89.830 Post bariatric hypoglycemia (billable)E89.838 Other postprocedural hypoglycemia (billable)Chapter 5. Mental, Behavioral & Neurodevelopmental (1 new)
F64.A Gender identity disorder, in remission (billable)Chapter 9. Circulatory System (9 new)
I42.00 Dilated cardiomyopathy, unspecified (billable)I42.01 Familial-genetic dilated cardiomyopathy (billable)I42.09 Other dilated cardiomyopathy (billable)I42.81 Arrhythmogenic cardiomyopathy (billable)I42.89 Other cardiomyopathies not elsewhere classified (billable)I47.22 Catecholaminergic polymorphic ventricular tachycardia [CPVT] (billable)I49.81 Brugada syndrome (billable)I49.82 Ventricular bigeminy (billable)I49.89 Other specified cardiac arrhythmias not elsewhere classified (billable)Chapter 10. Respiratory System (7 new)
J34.83 Odontogenic sinusitis (category header)J34.830 Odontogenic sinusitis, maxillary sinus (billable)J34.831 Odontogenic sinusitis, ethmoid sinus (billable)J34.832 Odontogenic sinusitis, frontal sinus (billable)J34.833 Odontogenic sinusitis, sphenoid sinus (billable)J34.839 Odontogenic sinusitis, unspecified (billable)J4B Pulmonary mycetoma (billable)Chapter 11. Digestive System (8 new)
K31.B Hypertrophic pyloric stenosis, in childhood (billable)K6A Diseases of the pelvis, not elsewhere classified (category header)K6A.0 Pelvic abscess (category header)K6A.01 Prevesical abscess (billable)K6A.09 Other pelvic abscess (billable)K6A.8 Other diseases of the pelvis, not elsewhere classified (billable)K74.0A Hepatic fibrosis, moderate fibrosis (billable)K76.83 Intestinal failure-associated liver disease (billable)Chapter 12. Skin & Subcutaneous Tissue (1 new)
L02.237 Carbuncle of flank (billable)Chapter 13. Musculoskeletal & Connective Tissue (33 new)
M04.3 VEXAS syndrome (billable)M67.A Plantar fasciitis (category header)M67.A0 Plantar fasciitis, foot (category header)M67.A01 Plantar fasciitis, right foot (billable)M67.A02 Plantar fasciitis, left foot (billable)M67.A09 Plantar fasciitis, unspecified foot (billable)M72.20 Plantar fascial fibromatosis, unspecified foot (billable)M72.21 Plantar fascial fibromatosis, right foot (billable)M72.22 Plantar fascial fibromatosis, left foot (billable)M86.8X11 Other osteomyelitis, right shoulder (billable)M86.8X12 Other osteomyelitis, left shoulder (billable)M86.8X19 Other osteomyelitis, unspecified shoulder (billable)M86.8X21 Other osteomyelitis, right upper arm (billable)M86.8X22 Other osteomyelitis, left upper arm (billable)M86.8X29 Other osteomyelitis, unspecified upper arm (billable)M86.8X31 Other osteomyelitis, right forearm (billable)M86.8X32 Other osteomyelitis, left forearm (billable)M86.8X39 Other osteomyelitis, unspecified forearm (billable)M86.8X41 Other osteomyelitis, right hand (billable)M86.8X42 Other osteomyelitis, left hand (billable)M86.8X49 Other osteomyelitis, unspecified hand (billable)M86.8X51 Other osteomyelitis, right thigh (billable)M86.8X52 Other osteomyelitis, left thigh (billable)M86.8X59 Other osteomyelitis, unspecified thigh (billable)M86.8X61 Other osteomyelitis, right lower leg (billable)M86.8X62 Other osteomyelitis, left lower leg (billable)M86.8X69 Other osteomyelitis, unspecified lower leg (billable)M86.8X71 Other osteomyelitis, right ankle and foot (billable)M86.8X72 Other osteomyelitis, left ankle and foot (billable)M86.8X79 Other osteomyelitis, unspecified ankle and foot (billable)M86.8X80 Other osteomyelitis, skull (billable)M86.8X81 Other osteomyelitis, face and sinuses (billable)M86.8X89 Other osteomyelitis, other site (billable)Chapter 14. Genitourinary System (3 new)
N99.86 Intraoperative and postprocedural complications and disorders of breast (category header)N99.860 Intraoperative and postprocedural nipple ischemia (billable)N99.861 Intraoperative and postprocedural nipple necrosis (billable)Chapter 15. Pregnancy, Childbirth & the Puerperium (56 new)
Chapter 15 adds 56 codes, mostly ectopic pregnancy site specificity and vanishing twin syndrome detail. Obstetric coding sits outside Medicare Advantage risk adjustment, so these are included for completeness.
O00.12 Interstitial ectopic pregnancy without intrauterine pregnancy (category header)O00.121 Right interstitial ectopic pregnancy without intrauterine pregnancy (billable)O00.122 Left interstitial ectopic pregnancy without intrauterine pregnancy (billable)O00.129 Unspecified interstitial ectopic pregnancy without intrauterine pregnancy (billable)O00.13 Interstitial ectopic pregnancy with intrauterine pregnancy (category header)O00.131 Right interstitial ectopic pregnancy with intrauterine pregnancy (billable)O00.132 Left interstitial ectopic pregnancy with intrauterine pregnancy (billable)O00.139 Unspecified interstitial ectopic pregnancy with intrauterine pregnancy (billable)O00.3 Cesarean scar ectopic pregnancy (category header)O00.31 Cesarean scar ectopic pregnancy without intrauterine pregnancy (billable)O00.32 Cesarean scar ectopic pregnancy with intrauterine pregnancy (billable)O00.4 Cervical ectopic pregnancy (category header)O00.41 Cervical ectopic pregnancy without intrauterine pregnancy (billable)O00.42 Cervical ectopic pregnancy with intrauterine pregnancy (billable)O00.5 Cornual ectopic pregnancy (category header)O00.51 Cornual ectopic pregnancy without intrauterine pregnancy (category header)O00.511 Right cornual ectopic pregnancy without intrauterine pregnancy (billable)O00.512 Left cornual ectopic pregnancy without intrauterine pregnancy (billable)O00.519 Unspecified cornual ectopic pregnancy without intrauterine pregnancy (billable)O00.52 Cornual ectopic pregnancy with intrauterine pregnancy (category header)O00.521 Right cornual ectopic pregnancy with intrauterine pregnancy (billable)O00.522 Left cornual ectopic pregnancy with intrauterine pregnancy (billable)O00.529 Unspecified cornual ectopic pregnancy with intrauterine pregnancy (billable)O31.4 Continuing pregnancy after vanishing twin syndrome of one fetus or more (category header)O31.40 Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester (category header)O31.40X0 Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, not applicable or unspecified (billable)O31.40X1 Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 1 (billable)O31.40X2 Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 2 (billable)O31.40X3 Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 3 (billable)O31.40X4 Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 4 (billable)O31.40X5 Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 5 (billable)O31.40X9 Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, other fetus (billable)O31.41 Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester (category header)O31.41X0 Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, not applicable or unspecified (billable)O31.41X1 Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 1 (billable)O31.41X2 Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 2 (billable)O31.41X3 Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 3 (billable)O31.41X4 Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 4 (billable)O31.41X5 Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 5 (billable)O31.41X9 Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, other fetus (billable)O31.42 Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester (category header)O31.42X0 Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, not applicable or unspecified (billable)O31.42X1 Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 1 (billable)O31.42X2 Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 2 (billable)O31.42X3 Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 3 (billable)O31.42X4 Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 4 (billable)O31.42X5 Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 5 (billable)O31.42X9 Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, other fetus (billable)O31.43 Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester (category header)O31.43X0 Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, not applicable or unspecified (billable)O31.43X1 Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 1 (billable)O31.43X2 Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 2 (billable)O31.43X3 Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 3 (billable)O31.43X4 Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 4 (billable)O31.43X5 Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 5 (billable)O31.43X9 Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, other fetus (billable)Chapter 17. Congenital Malformations (9 new)
Q87.A Loeys-Dietz syndrome (billable)QA1 Genetic disorders associated with neoplasms, not elsewhere classified (category header)QA1.7 Inherited neoplasm predisposition syndromes involving multiple systems, not elsewhere classified (category header)QA1.71 Lynch syndrome (billable)QA1.79 Other inherited neoplasm predisposition syndrome of multiple systems (category header)QA1.790 Familial cancer syndrome with pathogenic BRCA1 mutation (billable)QA1.791 Familial cancer syndrome with pathogenic BRCA2 mutation (billable)QA1.792 Li Fraumeni syndrome (billable)QA1.798 Other inherited neoplasm predisposition syndrome of multiple systems (billable)Chapter 18. Symptoms, Signs & Abnormal Findings (1 new)
R78.72 Abnormal gadolinium level in blood (billable)Chapter 19. Injury, Poisoning & External Causes (85 new)
Chapter 19 holds 85 of the 238 additions, almost entirely toxic-effect codes split from the deleted T52.8X family (alkenes, cycloparaffins, hexamethylene diisocyanate, and medetomidine). These are low-relevance for most risk adjustment work and are listed here for completeness.
T52.81 Toxic effects of alkenes (category header)T52.811 Toxic effect of alkenes, accidental (unintentional) (category header)T52.811A Toxic effect of alkenes, accidental (unintentional), initial encounter (billable)T52.811D Toxic effect of alkenes, accidental (unintentional), subsequent encounter (billable)T52.811S Toxic effect of alkenes, accidental (unintentional), sequela (billable)T52.812 Toxic effect of alkenes, intentional self-harm (category header)T52.812A Toxic effect of alkenes, intentional self-harm, initial encounter (billable)T52.812D Toxic effect of alkenes, intentional self-harm, subsequent encounter (billable)T52.812S Toxic effect of alkenes, intentional self-harm, sequela (billable)T52.813 Toxic effect of alkenes, assault (category header)T52.813A Toxic effect of alkenes, assault, initial encounter (billable)T52.813D Toxic effect of alkenes, assault, subsequent encounter (billable)T52.813S Toxic effect of alkenes, assault, sequela (billable)T52.814 Toxic effect of alkenes, undetermined (category header)T52.814A Toxic effect of alkenes, undetermined, initial encounter (billable)T52.814D Toxic effect of alkenes, undetermined, subsequent encounter (billable)T52.814S Toxic effect of alkenes, undetermined, sequela (billable)T52.82 Toxic effects of cycloparaffins (category header)T52.821 Toxic effect of cycloparaffins, accidental (unintentional) (category header)T52.821A Toxic effect of cycloparaffins, accidental (unintentional), initial encounter (billable)T52.821D Toxic effect of cycloparaffins, accidental (unintentional), subsequent encounter (billable)T52.821S Toxic effect of cycloparaffins, accidental (unintentional), sequela (billable)T52.822 Toxic effect of cycloparaffins, intentional self-harm (category header)T52.822A Toxic effect of cycloparaffins, intentional self-harm, initial encounter (billable)T52.822D Toxic effect of cycloparaffins, intentional self-harm, subsequent encounter (billable)T52.822S Toxic effect of cycloparaffins, intentional self-harm, sequela (billable)T52.823 Toxic effect of cycloparaffins, assault (category header)T52.823A Toxic effect of cycloparaffins, assault, initial encounter (billable)T52.823D Toxic effect of cycloparaffins, assault, subsequent encounter (billable)T52.823S Toxic effect of cycloparaffins, assault, sequela (billable)T52.824 Toxic effect of cycloparaffins, undetermined (category header)T52.824A Toxic effect of cycloparaffins, undetermined, initial encounter (billable)T52.824D Toxic effect of cycloparaffins, undetermined, subsequent encounter (billable)T52.824S Toxic effect of cycloparaffins, undetermined, sequela (billable)T52.89 Toxic effects of other organic solvents (category header)T52.891 Toxic effect of other organic solvents, accidental (unintentional) (category header)T52.891A Toxic effect of other organic solvents, accidental (unintentional), initial encounter (billable)T52.891D Toxic effect of other organic solvents, accidental (unintentional), subsequent encounter (billable)T52.891S Toxic effect of other organic solvents, accidental (unintentional), sequela (billable)T52.892 Toxic effect of other organic solvents, intentional self-harm (category header)T52.892A Toxic effect of other organic solvents, intentional self-harm, initial encounter (billable)T52.892D Toxic effect of other organic solvents, intentional self-harm, subsequent encounter (billable)T52.892S Toxic effect of other organic solvents, intentional self-harm, sequela (billable)T52.893 Toxic effect of other organic solvents, assault (category header)T52.893A Toxic effect of other organic solvents, assault, initial encounter (billable)T52.893D Toxic effect of other organic solvents, assault, subsequent encounter (billable)T52.893S Toxic effect of other organic solvents, assault, sequela (billable)T52.894 Toxic effect of other organic solvents, undetermined (category header)T52.894A Toxic effect of other organic solvents, undetermined, initial encounter (billable)T52.894D Toxic effect of other organic solvents, undetermined, subsequent encounter (billable)T52.894S Toxic effect of other organic solvents, undetermined, sequela (billable)T59.82 Toxic effects of hexamethylene diisocyanate (category header)T59.821 Toxic effect of hexamethylene diisocyanate, accidental (unintentional) (category header)T59.821A Toxic effect of hexamethylene diisocyanate, accidental (unintentional), initial encounter (billable)T59.821D Toxic effect of hexamethylene diisocyanate, accidental (unintentional), subsequent encounter (billable)T59.821S Toxic effect of hexamethylene diisocyanate, accidental (unintentional), sequela (billable)T59.822 Toxic effect of hexamethylene diisocyanate, intentional self-harm (category header)T59.822A Toxic effect of hexamethylene diisocyanate, intentional self-harm, initial encounter (billable)T59.822D Toxic effect of hexamethylene diisocyanate, intentional self-harm, subsequent encounter (billable)T59.822S Toxic effect of hexamethylene diisocyanate, intentional self-harm, sequela (billable)T59.823 Toxic effect of hexamethylene diisocyanate, assault (category header)T59.823A Toxic effect of hexamethylene diisocyanate, assault, initial encounter (billable)T59.823D Toxic effect of hexamethylene diisocyanate, assault, subsequent encounter (billable)T59.823S Toxic effect of hexamethylene diisocyanate, assault, sequela (billable)T59.824 Toxic effect of hexamethylene diisocyanate, undetermined (category header)T59.824A Toxic effect of hexamethylene diisocyanate, undetermined, initial encounter (billable)T59.824D Toxic effect of hexamethylene diisocyanate, undetermined, subsequent encounter (billable)T59.824S Toxic effect of hexamethylene diisocyanate, undetermined, sequela (billable)T65.85 Toxic effect of medetomidine (category header)T65.851 Toxic effect of medetomidine, accidental (unintentional) (category header)T65.851A Toxic effect of medetomidine, accidental (unintentional), initial encounter (billable)T65.851D Toxic effect of medetomidine, accidental (unintentional), subsequent encounter (billable)T65.851S Toxic effect of medetomidine, accidental (unintentional), sequela (billable)T65.852 Toxic effect of medetomidine, intentional self-harm (category header)T65.852A Toxic effect of medetomidine, intentional self-harm, initial encounter (billable)T65.852D Toxic effect of medetomidine, intentional self-harm, subsequent encounter (billable)T65.852S Toxic effect of medetomidine, intentional self-harm, sequela (billable)T65.853 Toxic effect of medetomidine, assault (category header)T65.853A Toxic effect of medetomidine, assault, initial encounter (billable)T65.853D Toxic effect of medetomidine, assault, subsequent encounter (billable)T65.853S Toxic effect of medetomidine, assault, sequela (billable)T65.854 Toxic effect of medetomidine, undetermined (category header)T65.854A Toxic effect of medetomidine, undetermined, initial encounter (billable)T65.854D Toxic effect of medetomidine, undetermined, subsequent encounter (billable)T65.854S Toxic effect of medetomidine, undetermined, sequela (billable)Chapter 21. Factors Influencing Health Status (Z codes) (17 new)
Z68.18 Body mass index [BMI] 18.4 or less, adult (billable)Z68.19 Body mass index [BMI] 18.5-19.9, adult (billable)Z77.013 Contact with and (suspected) exposure to gadolinium (billable)Z77.32 Contact with and (suspected) exposure to burn pits in war theater (billable)Z77.33 Contact with and (suspected) exposure to Agent Orange (billable)Z77.4 Contact with and (suspected) exposure to blast overpressure (category header)Z77.40 Contact with and (suspected) exposure to unspecified blast overpressure (billable)Z77.41 Contact with and (suspected) exposure to low-level blast overpressure (billable)Z77.42 Contact with and (suspected) exposure to high-level blast overpressure (billable)Z77.49 Contact with and (suspected) exposure to other blast overpressure (billable)Z86.17 Personal history of Clostridioides difficile infection (billable)Z87.8901 Personal history of social gender transition (billable)Z87.8902 Personal history of medical gender transition (billable)Z87.8903 Personal history of surgical gender transition (billable)Z87.8904 Personal history of intersex surgery (billable)Z87.8909 Personal history of unspecified gender transition (billable)Z87.893 Personal history of gender detransition (billable)How should coders prepare for the FY2027 cutover?
Audit your top codes. Pull your most-captured codes and check them against the deleted and demoted lists. Replace I42.0, I42.8, I49.8, S23.420, and T52.8X favorites now, not in October.Update templates and pick lists. Fix encounter templates, problem-list pick lists, and superbills before the cutover, not after.Flag the new specificity. Queue documentation queries for cardiomyopathy type, arrhythmia type, low BMI, exposure history, and inherited syndromes so the detail is in the note.Hold the RAF math. Do not assume an HCC or RAF value on any new code until CMS publishes the FY2027 mapping.Re-run a sample. Test a batch of recent charts against the FY2027 set to see where your specificity has to change.The codes are final. The risk adjustment mapping is the piece still to come, and we will update this page the day it lands.